Phibro Animal Health Corp
Company Profile
Business description
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
Contact
300 Frank W. Burr Boulevard
Suite 21, 3rd Floor
Glenpointe Centre East
TeaneckNJ07666-6712
USAT: +1 201 329-7300
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
30 June 2025
Employees
1,940
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,341.00 | 53.10 | 0.64% |
| CAC 40 | 7,547.09 | 8.78 | -0.12% |
| DAX 40 | 22,344.79 | 81.04 | -0.36% |
| Dow JONES (US) | 40,104.73 | 422.89 | -1.04% |
| FTSE 100 | 8,458.50 | 4.96 | -0.06% |
| HKSE | 22,119.41 | 111.30 | 0.51% |
| NASDAQ | 17,099.32 | 361.99 | -2.07% |
| Nikkei 225 | 36,045.38 | 205.39 | 0.57% |
| NZX 50 Index | 11,903.31 | 122.14 | -1.02% |
| S&P 500 | 5,478.08 | 82.75 | -1.49% |
| S&P/ASX 200 | 8,126.20 | 55.60 | 0.69% |
| SSE Composite Index | 3,279.03 | 7.62 | -0.23% |